Sex difference in the prevalence of left ventricular hypertrophy in dialysis patients

American Journal of Nephrology

Volumn 29, Issue 5, 2009, Pages 398-405

  Cheng, Li Tao ^a   Gao, Yan Li ^a,c   Tian, Jun Ping ^a,b   Gu, Yue ^a   Zhang, Li ^a   Bi, Shu Hong ^a   Tang, Wen ^a   Lindholm, Bengt ^d   Wang, Tao ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Comorbidity; Diabetes; Hemodialysis; Hypertension, uncontrolled; Left ventricular hypertrophy; Left ventricular mass index; Peritoneal dialysis

Indexed keywords

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY SURFACE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; TREATMENT DURATION;

ADULT; AGED; BODY HEIGHT; BODY SURFACE AREA; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; SEX FACTORS;

EID: 55449096405     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000171378     Document Type: Article

References (32)

1. Liao Y, Cooper RS, Mensah GA, McGee DL: Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation 1995;92:805-810.
2. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996;11: 1277-1285.
3. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47:186-192.
4. Gardin JM, Wagenknecht LE, Anton-Culver H, Flack J, Gidding S, Kurosaki T, Wong ND, Manolio TA: Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation 1995;92:380-387.
5. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med 1989;110:101-107.
6. Bruno G, Giunti S, Bargero G, Ferrero S, Pagano G, Perin PC: Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in type 2 diabetes: the Casale Monferrato Study. Diabet Med 2004;21:823-828.
7. Miskulin DC, Athienites NV, Yan G, Martin AA, Ornt DB, Kusek JW, Meyer KB, Levey AS, Hemodialysis (HEMO) Study Group: Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int 2001;60:1498-1510.
8. Wicks MN, Milstead EJ, Hathaway DK, Cetingok M: Subjective burden and quality of life in family caregivers of patients with end stage renal disease. ANNA J 1997;24:527-528.
9. Agodoa LY, Jones CA, Held PJ: End-stage renal disease in the USA: data from the United States Renal Data System. Am J Nephrol 1996;16:7-16.
10. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS, CREED Investigators: Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001; 12: 2768-2774.
11. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566.
12. de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH: Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994;23:600-606.
13. Stevenson PH: Height-weight-surface formula for the estimation of body surface area in Chinese subjects. Chin J Physiol 1937;3: 327-334.
14. Du Bois D, Du Bois EF: A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 1989; 5: 303-311.
15. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH: Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995;25:1056-1062.
16. Daugirdas JT: Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995;2:295-304.
17. Nolph KD, Moore HL, Prowant B, Meyer M, Twardowski ZJ, Khanna R, Ponferrada L, Keshaviah P: Cross-sectional assessment of weekly urea and creatinine clearance and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993;13:178-183.
18. Watson P, Watson I, Batt R: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutrit 1980;33:27-39.
19. Jabary NS, Herrero AM, Gonzalez JA: The use of antihypertensive therapy in Spain (1986-1994). Am J Hypertens 2000; 13:607-610.
20. Moon KH, Song IS, Yang WS, Shin YT, Kim SB, Song JK, Park JS: Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients. Am J Nephrol 2000;20:396-401.
21. Foley RN, Parfrey PS, Sarnak M J: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9:S16-S23.
22. Gunal Al, Ilkay E, Kirciman E, Karaca I, Dogukan A, Celiker H: Blood pressure control and left ventricular hypertrophy in long-term CAPD and hemodialysis patients: a cross-sectional study. Perit Dial Int 2003;23: 563-567.
23. Canziani ME, Cendoroglo Neto M, Saragoca MA, Cassiolato JL, Ramos OL, Ajzen H, Draibe SA: Hemodialysis versus continuous ambulatory peritoneal dialysis: effects on the heart. Artif Organs 1995; 19:241-244.
24. Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, Giacone G, Cottini E, Tripepi G, Malatino LS, Zoccali C: Longterm CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1459-1464.
25. Marcus R, Krause L, Weder AB, Domin-guez-Meja A, Schork NJ, Julius S: Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994;90:928-936.
26. Tenenbaum A, Fisman EZ, Schwammenthal E, Adler Y, Benderly M, Motro M, Shemesh J: Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus. Cardiovasc Diabetol 2003;2:14.
27. Stehman-Breen C, Anderson G, Gibson D, Kausz AT, Ott S: Pharmacokinetics of oral micronized beta-estradiol in postmeno-pausal women receiving maintenance hemo-dialysis. Kidney Int 2003;64:290-294.
28. Price TM, Dupuis RE, Carr BR, Stanczyk FZ, Lobo RA, Droegemueller W: Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis. Am J Obstet Gynecol 1993; 168: 1400-1406.
29. Zabalgoitia M, Ur Rahman SN, Haley WE, Oneschuk L, Yarrows S, Yunis C, Lucas C, Linn W, Krause L, Amerena J: Gender dimorphism in cardiac adaptation to hypertension is unveiled by prior treatment and efficacy. Am J Cardiol 1996;78:838-840.
30. Wallen WJ, Cserti C, Belanger MP, Wittnich C: Gender-differences in myocardial adaptation to afterload in normotensive and hypertensive rats. Hypertension 2000;36:774-779.
31. Vonesh EF, Moran J: Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999; 10:354-365.
32. Stack AG: Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis 2003;41:310-318